Which insurance providers cover yervoy?

Short answer: In the U.S., Yervoy (ipilimumab) is generally covered by Medicare Part B and by most private insurers for approved cancer indications, but coverage varies by plan and typically requires prior authorization.

What that usually means
- Medicare: Often covered under Part B with standard Part B cost-sharing (deductible and 20% coinsurance after the deductible).
- Private/commercial plans: Most major insurers (examples include Aetna, Anthem/Blue Cross, Cigna, UnitedHealthcare, Humana, Kaiser, etc.) cover ipilimumab when prescribed for an approved indication, but you’ll usually need prior authorization and the specific costs can vary by plan.
- Where coverage can differ: The exact indication, line of therapy, and documentation requirements can affect approval and out-of-pocket costs.

What to do to confirm coverage for you
- Check your plan’s formulary or drug list for ipilimumab/Yervoy and confirm it’s covered under Part B (if you’re on Medicare) or the correct benefit.
- Contact your insurer’s benefits or member services to ask:
- Is ipilimumab covered for my cancer type and line of therapy?
- Are prior authorizations required? What documentation is needed?
- What will my deductible, coinsurance, or copay be, and are there any out-of-pocket maximums?
- Do I need authorization through a specific infusion center or oncology practice?
- Talk with your oncology clinic’s financial navigator or social worker; they can help with pre-authorization and cost estimates.
- Ask about patient assistance: manufacturer programs for copay assistance or help with uninsured/underinsured patients; and local/state resources.

If you want, tell me your country and the exact insurer or plan name, and I can tailor steps and questions you should ask to that plan.